A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Frontier Medicines Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Boehringer Ingelheim
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Eli Lilly and Company
Incyte Corporation
BicycleTx Limited
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
Ankyra Therapeutics, Inc
Daiichi Sankyo
N-Power Medicine
ViroMissile, Inc.
Eli Lilly and Company
AstraZeneca
Pfizer
Astellas Pharma Inc
Avenzo Therapeutics, Inc.
IntoCell, Inc
Pfizer
Pfizer
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Mirati Therapeutics Inc.
InSilico Medicine Hong Kong Limited
ALX Oncology Inc.
Clasp Therapeutics, Inc.
Genentech, Inc.
Eli Lilly and Company
NiKang Therapeutics, Inc.
Incyte Corporation
Werewolf Therapeutics, Inc.
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Prelude Therapeutics
DualityBio Inc.
Kyowa Kirin Co., Ltd.
Pfizer
Eli Lilly and Company
IDEAYA Biosciences
Plexium, Inc.
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Pfizer
GlaxoSmithKline